From November 31 to November 2, Berlin is the setting for the Cannabinoid 2019 conference. The conference, organized by the International Association for Cannabinoid Medicines (IACM) aims – just like the IACM itself – to advance the knowledge on cannabis, cannabinoids, the endocannabinoid system and their therapeutic potential.
As usual, Bedrocan will be present at the IACM conference. “The IACM conference always adheres to present the highest quality science, with a strong focus on the patients’ perspective. That’s why we feel the need to be there”, says Bedrocan’s Clinical Research Coordinator dr. Mikael Kowal. “This year we are very pleased that Professor Albert Dahan (Leiden University Medical Centre, see picture) will have the opportunity to present the results of a clinical study on the effects of standardised medicinal cannabis products on fibromyalgia symptoms.”
The IACM Cannabinoid 2019 Conference
31 October – 2 November 2019 | Berlin
Meet us at booth B1